Trademark Overview
On Saturday, June 14, 2025, a trademark application was filed for DECIPHERA ACCESSPOINT with the United States Patent and Trademark Office. The USPTO has given the DECIPHERA ACCESSPOINT trademark a serial number of 99234759. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, June 14, 2025. This trademark is owned by Deciphera Pharmaceuticals, LLC. The DECIPHERA ACCESSPOINT trademark is filed in the Advertising, Business and Retail Services, Personal, Legal & Social Services, Insurance & Financial Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing information regarding healthcare insurance plans, medication insurance coverage, payor policies, reimbursement, patient financial assistance, and co-pay support programs; Administration of patient support programs for providing financial assistance for prescription medications; Providing insurance verification, prior authorization, benefit verification, claims processing and appeal support services for prescription medications; Providing financial support, financial advice and educational financial information regarding prescription medications
Provision of consumer information for healthcare providers and patients regarding prescription medications, reimbursements, rebates and coupons, insurance costs and discounts, and financial assistance resources; Business administration of patient support programs; Providing information about medical records coding, billing, and compliance for patients and healthcare providers
Providing patient advocate and case management services for the procurement, administration, adherence, and compliance related to prescription medications and treatment protocols; Providing personal support services to patients with treatment adherence challenges
Medical services, namely, providing information to healthcare providers and patients in connection with diseases, disease management and treatments, prescription medications, treatment protocols, and recommended resources for patients; Medical services, namely, patient support programs for providing temporary supply of prescription medication to eligible patients, assisting patients to obtain prescription medication at reduced prices, and facilitate adherence to treatment protocols and medication compliance
